why choose us

First received: October 03, 2023

Clinical Trial: A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetic Peripheral Neuropathy

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Randomized, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Brief Summary: The main purpose of this study is to determine the safety and efficacy of LY3556050 versus placebo in participants with diabetic peripheral neuropathic pain (DPNP).The study will lasts approximately 24 weeks, across 3 study periods.

Read more